ICD-10 Coding for Obesity related to FTO gene variant and metformin use(E66.01)
Complete ICD-10-CM coding and documentation guide for Obesity related to FTO gene variant and metformin use. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Obesity related to FTO gene variant and metformin use
Key Information: ICD-10 code for FTO gene obesity
Essential facts and insights about Obesity related to FTO gene variant and metformin use
Primary ICD-10-CM Code for fat mass and obesity gene metformin
Decision Criteria
clinical Criteria
- BMI ≥40 with FTO variant
documentation Criteria
- Genetic test results must be included
Applicable To
- Obesity with BMI ≥40
- Obesity with confirmed FTO variant
Excludes
- Obesity due to endocrine disorders (E03.9)
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Long-term (current) use of oral hypoglycemic drugs
Z79.84Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Other obesity
E66.09Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Obesity related to FTO gene variant and metformin use to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code E66.01.
Impact
Clinical: Misdiagnosis of obesity type., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.
Mitigation Strategy
Ensure genetic test results are filed., Verify documentation before coding.
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate patient records.
Mitigation Strategy
Verify and document metformin use for at least 6 months.
Impact
Failure to document genetic test results can lead to audit issues.
Mitigation Strategy
Ensure all genetic tests are documented and accessible.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Obesity related to FTO gene variant and metformin use, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Obesity related to FTO gene variant and metformin use
Use these documentation templates to ensure complete and accurate documentation for Obesity related to FTO gene variant and metformin use. These templates include all required elements for proper coding and billing.
Obesity management with FTO variant
Specialty: EndocrinologyRequired Elements
- Genetic test results
- BMI measurements
- Medication history
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Obesity related to FTO gene variant and metformin use? Ask your questions below.